Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

VENTECH

Ventech is a French Venture Capital firm founded in 1998 and regulated by the French Financial Authority -AMF- (GP 98-39). Ventech currently manages €173 million through two funds.Ventech invests in the first institutional round of financing in start-up companies active in Information Technology and Biotechnology, mainly in France.
Our mission is to invest in ambitious projects with a potential to become leading companies in their market, most often at an international level. Our team gathers highly complementary skills, built through international experiences in operations, private equity and strategy both in start-up as well as in large corporations.
Our approach to Venture Capital can be characterized by the importance we attach to the three following critical areas:
A collegial team work organized in a true partnership
A first-rate and nearly exhaustive deal flow in France
A value-added approach based on a strong operational experience and a long term vision.


Contact Details:
5/7 rue de Monttessuy
Paris
Cedex
75340
France
Tel:33(0) 1 58 19 21 50
Fax:33(0) 1 58 19 21 60
Email:contact@ventech.fr
WWW:

www.ventech.fr/




BioNews Results for VENTECH:

YSIOS, LSP and VENTECH led this financing round together with Genetrix and also joined by new ...
PipelineReview:  Nov 13 2009 12:39AM Matching: ventech
BioVex Completes $70 Million Financing to Conclude Pivotal Study With Its Pioneering Cancer Treatment, OncoVEX
TickerTech.com:  Nov 12 2009 5:22PM Matching: ventech
Spanish biopharmaceutical company Cellerix raises another 27m
AltAssets.net:  Nov 12 2009 6:49PM Matching: ventech
Cellerix Raises EUR27 Million in a First Closing
KOTA Territory News:  Nov 12 2009 11:33AM Matching: ventech
Cellerix Raises EUR27 Million in a First Closing
Pharmacy Choice:  Nov 12 2009 3:46AM Matching: ventech
Promote your company here: BioNewsCast - Press Release Distribution

View more VENTECH news.

VENTECH Patents:

US Patent No.Title
5232911 Mixture of a non-covalent heterodimer complex and a basic amphiphatic peptide as cytotoxic agent
5164196 Crotoxin complex as cytotoxic agent

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 321 times since April 2007, the link to the organisation's website has been followed 58 times

Recent Search Terms used to find this page: ventech | ventech | .

Search for more companies in Paris

Search for more companies in Cedex



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for VENTECH

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.